BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 12218898)

  • 1. [Pathophysiology of thrombotic microangiopathies: current understanding].
    Coppo P; Veyradier A; Durey MA; Fremeaux-Bacchi V; Scrobohaci ML; Amesland F; Bussel A
    Ann Med Interne (Paris); 2002 May; 153(3):153-66. PubMed ID: 12218898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic microangiopathies: towards a pathophysiology-based classification.
    Coppo P; Veyradier A
    Cardiovasc Hematol Disord Drug Targets; 2009 Mar; 9(1):36-50. PubMed ID: 19275576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
    Shenkman B; Einav Y
    Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombotic microangiopathies: HUS/TTP. Physiopathological aspects].
    Sánchez Avalos JC
    Medicina (B Aires); 2000; 60(1):46-58. PubMed ID: 10835700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic microangiopathies: from animal models to human disease and cure.
    Caprioli J; Remuzzi G; Noris M
    Contrib Nephrol; 2011; 169():337-350. PubMed ID: 21252531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets: thrombotic thrombocytopenic purpura.
    George JN; Sadler JE; Lämmle B
    Hematology Am Soc Hematol Educ Program; 2002; ():315-34. PubMed ID: 12446430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
    Masset C; Dubois B; Rorive G
    Rev Med Liege; 2002 Jan; 57(1):33-9. PubMed ID: 11899496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a shared pathophysiology for thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome?
    Desch K; Motto D
    J Am Soc Nephrol; 2007 Sep; 18(9):2457-60. PubMed ID: 17687074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of thrombotic microangiopathies.
    Zheng XL; Sadler JE
    Annu Rev Pathol; 2008; 3():249-77. PubMed ID: 18215115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombotic thrombocytopenic purpura in children -- pathophysiologic mechanisms and their clinical significance].
    Korczowski B
    Med Wieku Rozwoj; 2005; 9(4):753-61. PubMed ID: 16733283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience.
    Kremer Hovinga JA; Studt JD; Alberio L; Lämmle B
    Semin Hematol; 2004 Jan; 41(1):75-82. PubMed ID: 14727262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
    Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
    Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor and thrombotic thrombocytopenic purpura.
    Raife TJ; Montgomery RR
    Curr Opin Hematol; 2000 Sep; 7(5):278-83. PubMed ID: 10961577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.